Minimal Risk of Persistent or Recurrent Hypoglycemia after MEN1-Related Insulinoma Surgery. A Large International Cohort Study

S. Nell (1) , P. Goudet (2) , A. Vella (3) , D. Bartsch (4) , N. Perrier (5) , C. Sturgeon (6) , B. Brunaud (7, 8) , E. Kebebew (9) , M.L. Brandi (10) , R. Zarnegar (11) , J. Pasternak (12) , H. M. Verkooijen (1) , I.H.M. Borel Rinkes (1) , G. D. Valk (1) , Mr Vriens (1)

1 University Medical Center [Utrecht]
2 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand
3 Mayo Clinic [Rochester]
4 Philipps Universität Marburg = Philipps University of Marburg
5 The University of Texas M.D. Anderson Cancer Center [Houston]
6 Northwestern University [Chicago, Ill. USA]
7 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
8 UL - Université de Lorraine
9 NIH - National Institutes of Health [Bethesda]
10 UniFI - Università degli Studi di Firenze = University of Florence
11 Weill Medical College of Cornell University [New York]
12 University Health Network

Mots clés: men1

Domaines: Sciences du Vivant [q-bio]; Médecine humaine et pathologie; Endocrinologie et métabolisme

S. Nell, P. Goudet, A. Vella, D. Bartsch, N. Perrier, et al.. Minimal Risk of Persistent or Recurrent Hypoglycemia after MEN1-Related Insulinoma Surgery. A Large International Cohort Study . the 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.(O21). ⟨hal-01664068⟩